冠状动脉再血管化在经过透导管大动脉置换的患者中
Stephen McHugh1, Haytham Allaham1, Diljon Chahal2
1University of Maryland Medical Center.
Cardiology clinics
|June 23, 2024
概括
对于需要通过导管进行大动脉置换 (TAVR) 和冠状动脉疾病治疗的患者,如果没有严重的冠状动脉阻塞,TAVR后的重血管化是安全的. 手术前的计算机断层扫描血管造影可以指导这个时间,避免侵入性手术.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 心脏外科手术 心脏外科手术
背景情况:
- 严重的大动脉狭窄 (AS) 和冠状动脉疾病 (CAD) 经常共存,造成复杂的管理挑战.
- 由于缺乏明确的指导方针,在接受过导管大动脉置换 (TAVR) 的患者中进行冠状动脉再血管化的最佳时间仍在争论中.
- 目前的临床实践缺乏整合TAVR和CAD管理的明确策略.
研究的目的:
- 评估TAVR后在同时患有严重AS和CAD的患者中进行冠状动脉再血管化的安全性和可行性.
- 探索术前TAVR计算机断层扫描血管学 (CTA) 在评估显著近端冠状动脉疾病中的实用性.
- 提供基于证据的建议,以指导在这个患者群体中重新血管化的时间.
主要方法:
- 对接受TAVR的严重AS和CAD患者的回顾性分析.
- 对前期冠状动脉再血管化的患者和没有前期冠状动脉再血管化的患者的结局进行比较.
- 与侵袭性冠状动脉血管学相比,TAVR CTA在识别显著近端冠状动脉疾病方面的准确性评估.
主要成果:
- 在TAVR后进行的重血管化被发现在没有高度近端冠状动脉疾病的患者中是安全的和可行的.
- 手术前的TAVR CTA在评估中等和高风险患者的显著近接冠状动脉疾病方面显示出潜在的实用性.
- 在选择的病例中,推迟再血管化直到TAVR后,并没有影响患者的治疗结果.
结论:
- 在TAVR后,冠状动脉复血管化可以安全地在没有临界近端冠状动脉疾病的患者中进行.
- TAVR CTA是一种有前途的非侵入性工具,用于评估冠状动脉解剖学和指导重血管化时间.
- 一种量身定制的方法,可能利用TAVR CTA,可以优化AS和CAD结合重症的管理.
更多相关视频
08:50Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
Published on: March 26, 2018
11.7K
06:59Improved Registration of 3D CT Angiography with X-ray Fluoroscopy for Image Fusion During Transcatheter Aortic Valve Implantation
Published on: June 3, 2018
10.6K
相关概念视频
Cardiac Catheterization I: Pre-Procedure Overview
3.4K
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
3.4K
Aortic Regurgitation III: Medical Management
598
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
598
Coronary Artery Disease V: Interprofessional Care
450
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
450
Acute Coronary Syndrome IV: Interprofessional Care
525
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
525
